Alnylam Pharmace. sell Biotechhunter
Start price
06.08.20
/
50%
€121.26
Target price
10.08.20
-
Performance (%)
-2.64%
End price
10.08.20
€118.06
Summary
This prediction ended on 10.08.20 with a price of €118.06. With a performance of -2.64%, the SELL prediction by Biotechhunter was trending in the right direction. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 0.118% | 0.118% | 51.226% | 60.454% |
| iShares Core DAX® | 1.822% | 3.926% | 23.507% | 67.355% |
| iShares Nasdaq 100 | 1.093% | -0.585% | 6.034% | 113.907% |
| iShares Nikkei 225® | 3.042% | 1.335% | 17.437% | 51.841% |
| iShares S&P 500 | 1.247% | 0.836% | 4.374% | 68.234% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Sell Alnylam Pharmace.